Entries tagged "Novartis"

You have executed a tag search on The Deal Pipeline. Below, you will find a comprehensive list of stories tagged "Novartis."

11 result(s) displayed (1 - 11 of 11)

Actavis eyes more acquisitions

Executives say the $8.5 billion purchase of Warner Chilcott will serve as a platform for further growth. Continue reading

Posted on May 21, 2013 9:56 AM

Risk arbitrage: July 19, 2010

Air Products and Chemicals increases its bid for Airgas, and Novartis intends to buy in Alcon shares through a stock swap of 2.8 Novartis shares for each share of Alcon. Continue reading

Posted on July 16, 2010 12:09 PM

Just one more question

Article One Partners enlists any and all sleuths to probe for weaknesses in patents. Continue reading

Posted on February 5, 2010 11:58 AM

Arbitrage: Feb. 8, 2010

Novartis will likely face a standoff with Alcon's special committee. Baker Hughes entered a timing agreement with regulators. Continue reading

Posted on February 5, 2010 11:56 AM

The marriage of theory and practice

Abigail Barrow and Steven Shapin on the interaction of science, technology and economic development. Continue reading

Posted on May 15, 2009 11:59 AM

Money, vaccines and lots of soap

Remember the bird flu? Now that another flu strain is threatening the globe, here's a look at where we stand drugwise. Continue reading

Posted on May 1, 2009 10:26 AM

Capital raising 101

Nine alternative measures for life sciences companies to raise funds in today's environment. Continue reading

Posted on April 7, 2009 2:35 PM

Paging Dr. Scholl

The consumer-products subplot in the pharmaceutical megamergers. Continue reading

Posted on March 20, 2009 1:59 PM

The big trial

From VC to licensing, Exelixis has done every kind of deal to keep itself afloat, except one. Is an acquisition next? Continue reading

Posted on March 6, 2009 11:29 AM

Private markets, public health

A new plan hopes FDA vouchers attract big cash and new cures for nasty diseases. Continue reading

Posted on January 9, 2009 2:08 PM

Litigation risk

FASB weighs requiring companies to estimate their exposure to legal damages; business tries to bury the idea. Continue reading

Posted on August 29, 2008 11:43 AM

Movable Type search results powered by Fast Search